Advances in the pathophysiology and treatment of relapsed/refractory Hodgkin’s lymphoma with an emphasis on targeted therapies and transplantation strategies

Hodgkin’s lymphoma (HL) is highly curable with first-line therapy. However, a minority of patients present with refractory disease or experience relapse after completion of frontline treatment. These patients are treated with salvage chemotherapy followed by autologous stem cell transplantation (ASC...

Descripción completa

Detalles Bibliográficos
Autores principales: Karantanos, Theodoros, Politikos, Ioannis, Boussiotis, Vassiliki A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5502320/
https://www.ncbi.nlm.nih.gov/pubmed/28701859
http://dx.doi.org/10.2147/BLCTT.S105458

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5502320/
https://www.ncbi.nlm.nih.gov/pubmed/28701859
http://dx.doi.org/10.2147/BLCTT.S105458

Ejemplares similares